NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 38 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $107,000 | – | 13,116 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $48,409,000 | 1.87% |
| RA Capital Management | 612,863 | $7,949,000 | 1.14% |
| TIGER MANAGEMENT L.L.C. | 650,915 | $8,442,000 | 1.13% |
| Opaleye Management Inc. | 175,200 | $2,272,000 | 1.12% |
| Rock Springs Capital Management LP | 489,000 | $6,342,000 | 0.52% |
| WALL STREET ASSOCIATES | 170,400 | $2,210,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 201,720 | $2,616,000 | 0.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 418,903 | $5,433,000 | 0.26% |
| SABBY MANAGEMENT, LLC | 384,734 | $4,990,000 | 0.21% |
| DAFNA Capital Management LLC | 15,000 | $195,000 | 0.19% |